Levodopa-induced dyskinesia: do current clinical trials hold hope for future treatment?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Levodopa-induced dyskinesia: do current clinical trials hold hope for future treatment?

Published:2023-12-27 Issue:1 Volume:25 Page:1-3
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Alsalmi Mohammed¹,Al-Kassmy Jawad²,Kang Woojin³,Palayew Michael²,Huot Philippe¹³⁴

Affiliation:

1. Movement Disorder Clinic, Division of Neurology, Department of Neurosciences, McGill University Health Centre, Montreal, QC, Canada

2. Royal College of Surgeons in Ireland, School of Medicine, Dublin, Ireland

3. Neurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), Montreal, QC, Canada

4. Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2023.2298345

Reference29 articles.

1. Sydney multicenter study of Parkinson's disease: Non‐ L ‐dopa–responsive problems dominate at 15 years

2. International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease

3. The serotonergic system in Parkinson's disease

4. Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites

5. Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP